Genetic alterations in primary cutaneous CD30+anaplastic large cell lymphoma

被引:59
作者
Mao, X
Orchard, G
Lillington, DM
Russell-Jones, K
Young, BD
Whittaker, S
机构
[1] St Thomas Hosp, St Johns Inst Dermatol, Skin Tumour Unit, London SE1 7EH, England
[2] St Bartholomews Hosp, UK Med Oncol Unit, London, England
[3] St Thomas Hosp, St Johns Inst Dermatol, Dept Dermatopathol, London SE1 7EH, England
关键词
D O I
10.1002/gcc.10184
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Primary cutaneous CD30+ ahaplastic large tell lymphoma (C-ALCL) represents a distinct clinical subtype of CD30+ anaplastic large cell lymphomas. The etiology and underlying molecular pathogenesis of C-ALCL remain unclear. This study aimed to investigate genetic changes in C-ALCL. Comparative genomic hybridization (CGH) analysis of 23 DNA samples from 15 C-ALCL cases identified chromosome imbalances, (CI) in 10 samples I from eight cases (43%). The mean number of CI per sample Was 2.09 +/- 3.86, with gains (2.00 +/- 3.85) more common than losses (0.09 +/- 0.29). The most frequent C! were gains of 1/1p and 5 (50%), and 6, 7, 8/8p, and 19 (38%). Microarray-based CGH analysis of six DNA. samples from five cases. with CI revealed genomic imbalances (GI) in all of the cases studied. This included oncogene copy number gains of FGFR1 (8p11) in three cases, and NRAS (1p13.2), MYCN (2p24.1); RAF1 (3p25), CTSB (8p22), FES (15q26.1) and CBFA2 (21q22.3) in two cases. Real-time PCR analysis of nine DNA samples from eight cases With Cl and GI detected amplifications of CTSB and RAF1 in seven cases (88%), REL (2p13p12) and JUNB (19p13.2) in six cases (75%), and MYCN and YES I, (18p11.3) in four cases (50%), Immunohistochemical staining of paraffin sections from six cases demonstrated expression of JUNB protein in five cases and BCL2 in three cases. These results reveal a consistent pattern of genetic alterations in C-ALCL and. provide the molecular basis for further investigation of this disease. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:176 / 185
页数:10
相关论文
共 44 条
  • [1] Bautista S, 1998, GENE CHROMOSOME CANC, V22, P268, DOI 10.1002/(SICI)1098-2264(199808)22:4<268::AID-GCC2>3.3.CO
  • [2] 2-U
  • [3] Primary and secondary cutaneous CD30+ lymphoproliferative disorders:: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment
    Bekkenk, MW
    Geelen, FAMJ
    Vader, PCV
    Heule, F
    Geerts, ML
    van Vloten, WA
    Meijer, CJLM
    Willemze, R
    [J]. BLOOD, 2000, 95 (12) : 3653 - 3661
  • [4] MORPHOLOGY IN KI-1(CD30) - POSITIVE NON-HODGKINS-LYMPHOMA IS CORRELATED WITH CLINICAL-FEATURES AND THE PRESENCE OF A UNIQUE CHROMOSOMAL ABNORMALITY, T(2 - 5)(P23 - Q35)
    BITTER, MA
    FRANKLIN, WA
    LARSON, RA
    MCKEITHAN, TW
    RUBIN, CM
    LEBEAU, MM
    STEPHENS, JK
    VARDIMAN, JW
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1990, 14 (04) : 305 - 316
  • [5] Degenerate oligonucleotide primed-polymerase chain reaction-based array comparative genomic hybridization for extensive amplicon profiling of breast cancers - A new approach for the molecular analysis of paraffin-embedded cancer tissue
    Daigo, Y
    Chin, SF
    Gorringe, KL
    Bobrow, LG
    Ponder, BAJ
    Pharoah, PDP
    Caldas, C
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (05) : 1623 - 1631
  • [6] The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30(+) lymphoproliferative disorders: Comparison with anaplastic large-cell lymphoma of nodal origin
    DeCoteau, JF
    Butmarc, JR
    Kinney, MC
    Kadin, ME
    [J]. BLOOD, 1996, 87 (08) : 3437 - 3441
  • [7] Translocations involving anaplastic lymphoma kinase (ALK)
    Duyster, J
    Bai, RY
    Morris, SW
    [J]. ONCOGENE, 2001, 20 (40) : 5623 - 5637
  • [8] IMMUNOHISTOCHEMICAL, MOLECULAR, AND CYTOGENETIC ANALYSIS OF A CONSECUTIVE SERIES OF 20 PERIPHERAL T-CELL LYMPHOMAS AND LYMPHOMAS OF UNCERTAIN LINEAGE, INCLUDING 12 KI-L POSITIVE LYMPHOMAS
    EBRAHIM, SAD
    LADANYI, M
    DESAI, SB
    OFFIT, K
    JHANWAR, SC
    FILIPPA, DA
    LIEBERMAN, PH
    CHAGANTI, RSK
    [J]. GENES CHROMOSOMES & CANCER, 1990, 2 (01) : 27 - 35
  • [9] Harris N. L., 2000, Histopathology (Oxford), V36, P69
  • [10] Herbst H, 1997, BRIT J DERMATOL, V137, P680